Webb1 feb. 2024 · View RUGEN HOLDINGS (CAYMAN) LIMITED's, GRAND CAYMAN, KY, patent portfolio profile on Patent Buddy. Patent Buddy is the world's most extensive database … WebbThis patent grant is currently assigned to Rugen Holdings (Cayman) Limited. The grantee listed for this patent is Rugen Holdings (Cayman) Limited. Invention is credited to Gideon Shapiro. United States Patent: 10,030,026: Shapiro: July 24, 2024: Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists
CONFECCIONES RUGEN SA - datocapital.es
Webb30 okt. 2024 · Rugen Holdings (Cayman) Limited, dba Rugen Therapeutics is a biotech company discovering and developing novel, first-in-class, small-molecule drugs with the … Webb29 okt. 2024 · Rugen Holdings (Cayman) Limited, dba Rugen Therapeutics is a biotech company discovering and developing novel, first-in-class, small-molecule drugs with the … seturn software solution
Rugen holdings cayman limited的专利 - 专利顾如
WebbFriday, October 30th 2024 at 12:00pm UTC Activities will support the clinical development of Rugen’s potential first-in-class, orally administered drug... samedi 13 août 2024 … Webb30 okt. 2024 · Rugen Holdings (Cayman) Limited, dba Rugen Therapeutics is a biotech company discovering and developing novel, first-in-class, small-molecule drugs with the … WebbU.S. Patent Number 10420768 for Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists setur shop and fly